NYSE : HAE

Haemonetics Corporation — Financial statements

Healthcare · Medical Devices · United States

Last price 119.65 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.44B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Haemonetics Corporation (HAE) reported revenue of 1.35B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Revenue1.35B1.33B1.36B1.31B1.17B993.20M
Cost of Revenue549.85M541.16M582.28M600.49M545.79M462.43M
Gross Profit802.16M792.87M778.55M708.57M622.87M530.77M
Selling, General & Admin445.11M438.54M422.05M418.82M373.95M332.20M
Research & Development59.43M58.80M61.13M52.23M49.08M45.98M
Amortization of Goodwill & Intangibles42.81M44.00M48.26M32.03M32.64M47.41M
Operating Expenses547.35M541.34M531.45M503.08M455.67M425.60M
Operating Income254.82M251.53M247.10M205.49M167.20M105.17M
Interest Expense-27.40M-19.30M-35.90M-19.50M-13.00M-5.80M
Currency Exchange Gain (Loss)-4.82M-5.11M
Other Non Operating Income (Expenses)-2.57M-9.19M13.55M6.48M-1.63M-11.32M
EBT Excluding Unusual Items220.03M217.93M224.75M192.47M152.57M88.05M
Merger & Restructuring Charges-9.83M-10.13M-45.91M-30.19M-11.55M-28.82M
Gain (Loss) on Sale of Investments4.90M4.90M
Gain (Loss) on Sale of Assets382.00K9.60M
Asset Writedown-86.55M-86.55M-2.39M-10.42M-5.20M
Other Unusual Items1.88M1.88M35.62M
Pretax Income130.44M128.03M212.07M151.87M141.40M63.63M
Income Tax Expense34.15M30.72M44.39M34.31M26.00M20.25M
Net Income96.29M97.31M167.68M117.56M115.40M43.38M
Net Income to Common96.29M97.31M167.68M117.56M115.40M43.38M
Shares Outstanding (Basic)46.49M47.18M50.33M50.71M50.78M51.05M
Shares Outstanding (Diluted)46.69M47.35M50.73M51.40M51.42M51.35M
EPS (Basic)2.072.063.332.322.270.85
EPS (Diluted)2.062.053.312.292.240.84
Free Cash Flow291.22M260.44M142.45M143.63M81.73M75.75M
Free Cash Flow Per Share6.245.502.812.791.591.48
Gross Margin59.33%59.43%57.21%54.13%53.30%53.44%
Operating Margin18.85%18.86%18.16%15.70%14.31%10.59%
Profit Margin7.12%7.29%12.32%8.98%9.88%4.37%
Free Cash Flow Margin21.54%19.52%10.47%10.97%6.99%7.63%
EBITDA358.79M357.15M355.99M294.11M252.01M191.72M
EBITDA Margin26.54%26.77%26.16%22.47%21.56%19.30%
D&A For EBITDA103.97M105.62M108.89M88.61M84.81M86.55M
EBIT254.82M251.53M247.10M205.49M167.20M105.17M
EBIT Margin18.85%18.86%18.16%15.70%14.31%10.59%
Effective Tax Rate26.18%24.00%20.93%22.59%18.39%31.83%
Advertising Expenses7.40M7.70M7.10M7.20M4.40M

Balance sheet

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents223.38M245.44M306.76M178.80M284.47M259.50M
Trading Asset Securities1.13M823.00K1.30M1.67M1.11M
Cash & Short-Term Investments224.52M246.26M308.07M180.47M285.58M259.50M
Receivables216.07M216.85M202.66M206.56M179.14M159.38M
Inventory306.74M306.37M365.14M317.20M259.38M293.03M
Prepaid Expenses62.23M63.82M58.83M63.16M43.92M40.90M
Other Current Assets1.28M1.57M278.00K1.51M1.70M3.23M
Total Current Assets810.83M834.88M934.98M768.90M769.72M756.03M
Property, Plant & Equipment303.78M345.38M331.54M366.63M364.30M311.23M
Long-Term Investments26.19M947.00K1.02M62.00K
Goodwill656.88M656.37M604.27M565.08M466.23M467.29M
Other Intangible Assets434.51M510.06M499.74M429.02M275.77M310.26M
Long-Term Deferred Tax Assets9.43M9.52M7.80M7.74M5.24M4.47M
Other Long-Term Assets123.77M38.77M71.59M58.16M53.56M10.46M
Total Assets2.37B2.40B2.45B2.20B1.93B1.86B
Accounts Payable56.34M51.06M67.00M73.36M63.93M58.37M
Accrued Expenses38.15M68.19M59.42M80.71M64.47M48.54M
Current Portion of Long-Term Debt4.96M5.01M303.56M10.23M11.78M215.96M
Current Portion of Leases9.24M8.11M8.13M7.16M7.20M
Current Unearned Revenue48.60M42.31M43.35M31.24M30.21M26.81M
Other Current Liabilities115.20M106.78M96.68M96.71M74.26M85.39M
Total Current Liabilities263.24M282.60M578.11M300.38M251.82M442.27M
Long-Term Debt1.17B1.22B921.23M797.56M755.91M559.44M
Long-Term Leases40.90M50.45M57.96M55.90M55.70M
Long-Term Deferred Tax Liabilities38.69M38.05M62.58M62.64M36.20M28.73M
Other Long-Term Liabilities57.17M18.50M17.74M17.08M17.00M24.17M
Total Liabilities1.53B1.60B1.63B1.24B1.12B1.11B
Common Stock455.00K453.00K482.00K508.00K504.00K511.00K
Additional Paid-In Capital566.76M554.14M523.26M634.63M594.71M572.48M
Retained Earnings311.52M279.34M352.17M360.46M253.17M202.39M
Comprehensive Income & Other-41.63M-37.61M-55.08M-35.63M-30.38M-25.95M
Shareholders' Equity837.10M796.32M820.84M959.96M818.00M749.42M
Total Liabilities & Equity2.37B2.40B2.45B2.20B1.93B1.86B
Total Debt1.17B1.27B1.28B873.88M830.76M838.30M
Net Cash (Debt)-949.64M-1.03B-975.28M-693.41M-545.18M-578.81M
Net Cash Per Share-20.34-21.72-19.22-13.49-10.60-11.27
Filing Date Shares Outstanding45.50M45.45M48.04M50.84M50.54M51.28M
Total Common Shares Outstanding45.47M45.25M48.22M50.79M50.45M51.12M
Working Capital547.60M552.28M356.86M468.52M517.91M313.76M
Book Value Per Share18.4117.6017.0218.9016.2114.66
Tangible Book Value-254.29M-370.10M-283.18M-34.14M76.00M-28.12M
Tangible Book Value Per Share-5.59-8.18-5.87-0.671.51-0.55
Land2.32M2.25M1.99M4.13M5.36M5.17M
Buildings109.73M109.79M105.08M124.34M127.63M104.36M
Machinery709.00M699.84M707.90M791.01M781.86M706.01M
Construction In Progress33.22M29.94M22.23M39.69M29.37M53.61M

Cash flow statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income96.29M97.31M167.68M117.56M115.40M43.38M
Depreciation & Amortization103.97M105.62M108.89M88.61M84.81M86.55M
Other Amortization6.10M6.10M6.70M8.60M8.50M11.80M
Loss (Gain) From Sale of Assets-714.00K-714.00K-15.70M-1.01M-943.00K-9.60M
Asset Writedown & Restructuring Costs86.55M86.55M2.39M10.42M607.00K10.75M
Stock-Based Compensation33.83M33.83M29.64M28.33M25.58M24.36M
Other Operating Activities-9.69M-11.81M-15.91M3.94M13.60M20.20M
Change in Accounts Receivable-18.14M-14.88M6.96M-24.19M-24.42M-34.97M
Change in Inventory43.06M47.36M-64.70M-60.06M30.75M24.31M
Change in Accounts Payable18.71M-16.57M-19.21M44.58M39.82M7.64M
Change in Income Taxes-1.78M-4.53M226.00K-983.00K1.69M2.87M
Change in Other Net Operating Assets-30.03M-35.03M-25.23M-34.05M-22.33M-15.02M
Operating Cash Flow328.15M293.22M181.72M181.75M273.06M172.26M
Capital Expenditures-36.93M-32.78M-39.28M-38.12M-191.33M-96.51M
Sale of Property, Plant & Equipment1.31M1.38M23.25M1.81M1.61M2.02M
Cash Acquisitions-60.18M-60.18M-150.91M-243.85M-2.85M-2.50M
Divestitures43.29M1.50M850.00K10.64M
Investment in Securities-26.99M-36.07M-17.14M-15.55M-33.20M
Other Investing Activities-46.00M-51.89M-21.11M-28.17M81.14M
Investing Cash Flow-168.78M-179.55M-161.90M-322.39M-143.79M-86.34M
Long-Term Debt Issued300.00M950.00M110.00M330.00M
Total Debt Issued300.00M300.00M950.00M110.00M330.00M
Long-Term Debt Repaid-306.25M-502.69M-72.25M-339.62M-17.50M
Total Debt Repaid-356.25M-306.25M-502.69M-72.25M-339.62M-17.50M
Net Debt Issued (Repaid)-56.25M-6.25M447.31M37.75M-9.62M-17.50M
Issuance of Common Stock7.50M7.89M8.33M7.21M7.02M6.55M
Repurchase of Common Stock-178.72M-180.00M-235.24M-5.88M-75.00M
Other Financing Activities-80.00K-102.00K-111.58M-922.00K-22.75M-4.80M
Financing Cash Flow-227.55M-178.46M108.82M38.16M-100.36M-15.75M
Foreign Exchange Rate Adjustments-1.34M3.46M-685.00K-3.19M-3.94M-2.98M
Net Cash Flow-69.51M-61.32M127.96M-105.67M24.97M67.19M
Free Cash Flow291.22M260.44M142.45M143.63M81.73M75.75M
Free Cash Flow Margin21.54%19.52%10.47%10.97%6.99%7.63%
Free Cash Flow Per Share6.245.502.812.791.591.48
Levered Free Cash Flow312.84M298.09M183.89M148.53M50.09M88.90M
Unlevered Free Cash Flow329.96M310.16M206.33M160.72M58.21M89.12M
Cash Interest Paid17.46M17.46M16.53M20.90M13.59M6.19M
Cash Income Tax Paid60.66M60.66M49.29M52.71M17.97M24.30M
Change in Working Capital11.82M-23.65M-101.96M-74.70M25.50M-15.18M

Ratios

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization5.44B2.51B3.17B4.33B4.17B3.26B
Enterprise Value6.39B3.37B4.15B5.01B4.72B3.81B
Last Close Price119.6554.0463.1985.3582.7563.85
PE Ratio58.1125.8118.9336.8736.1775.24
Forward PE21.7210.4613.2120.4925.4523.82
PS Ratio4.031.882.333.313.573.29
PB Ratio6.503.153.874.515.104.36
P/TBV Ratio54.93
P/FCF Ratio18.699.6422.2930.1851.0843.08
P/OCF Ratio16.598.5617.4723.8515.2918.95
PEG Ratio2.010.961.001.392.421.36
EV/Sales Ratio4.732.533.053.834.043.83
EV/EBITDA Ratio17.829.4411.6417.0418.7219.87
EV/EBIT Ratio25.0913.4116.7824.3828.2136.22
EV/FCF Ratio21.9512.9529.1034.8957.7150.28
Debt / Equity Ratio1.401.601.560.911.021.12
Debt / EBITDA Ratio3.183.473.492.873.284.14
Debt / FCF Ratio4.034.899.016.0810.1611.07
Net Debt / Equity Ratio1.131.291.190.720.670.77
Net Debt / EBITDA Ratio2.652.882.742.362.163.02
Net Debt / FCF Ratio3.263.956.854.836.677.64
Asset Turnover0.560.550.590.630.620.54
Inventory Turnover1.651.611.712.081.981.50
Quick Ratio1.671.640.881.291.840.95
Current Ratio3.082.951.622.563.061.71
Return on Equity (ROE)11.20%12.03%18.83%13.22%14.72%5.86%
Return on Assets (ROA)6.60%6.49%6.65%6.22%5.51%3.57%
Return on Invested Capital (ROIC)10.42%10.56%11.33%10.55%10.14%5.40%
Return on Capital Employed (ROCE)12.10%11.90%13.20%10.80%9.90%7.40%
Earnings Yield1.72%3.88%5.28%2.71%2.76%1.33%
FCF Yield5.35%10.37%4.49%3.31%1.96%2.32%
Buyback Yield / Dilution6.48%6.65%1.30%0.04%-0.13%-0.12%